Group B streptococcal disease: Black and Asian newborns at higher risk

Group B Streptococcus is the most common cause of life-threatening infection in newborns, and in the UK on average two babies a day develop the infection. Now, the charity Group B Strep Support has called for greater awareness of the disease and for hospitals to enroll in the ongoing GBS3 trial.

A new study led by the UK Health Security Agency (UKHSA) has found that rates of group B streptococcal (GBS) disease are significantly higher in infants of Black or Asian ethnicity, compared to infants of White ethnicity.1

            Group B streptococcal disease is the most common cause of life-threatening infection in newborn babies, causing a range of serious infections including pneumonia, meningitis and sepsis.2 In the UK, on average, two babies a day develop the infection, with one a week dying and one a week being left with life-changing disability.1

            A new study, published in the journal Pediatrics, used national laboratory data and NHS hospital records for England for the period 2016–2020. It found that: among infants of Black ethnicity, the overall rate of invasive GBS disease was 51% higher than for White infants; and, among infants of Asian ethnicity, the overall rate of GBS disease was 28% higher than for White infants.

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024